These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11021814)
1. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Maitra A; Molberg K; Albores-Saavedra J; Lindberg G Am J Pathol; 2000 Oct; 157(4):1105-11. PubMed ID: 11021814 [TBL] [Abstract][Full Text] [Related]
2. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786 [TBL] [Abstract][Full Text] [Related]
3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137 [TBL] [Abstract][Full Text] [Related]
4. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
5. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. MacGrogan D; Pegram M; Slamon D; Bookstein R Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype. Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496 [TBL] [Abstract][Full Text] [Related]
7. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis. Beghelli S; Orlandini S; Moore PS; Talamini G; Capelli P; Zamboni G; Falconi M; Scarpa A Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196 [TBL] [Abstract][Full Text] [Related]
8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719 [TBL] [Abstract][Full Text] [Related]
10. No SMAD4 hypermethylation in colorectal cancer. Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648 [TBL] [Abstract][Full Text] [Related]
11. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms. Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795 [TBL] [Abstract][Full Text] [Related]
12. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis. Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Hornick JL; Farraye FA; Odze RD Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765 [TBL] [Abstract][Full Text] [Related]
14. DPC4 gene in various tumor types. Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691 [TBL] [Abstract][Full Text] [Related]
15. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Iacobuzio-Donahue CA; Wilentz RE; Argani P; Yeo CJ; Cameron JL; Kern SE; Hruban RH Am J Surg Pathol; 2000 Nov; 24(11):1544-8. PubMed ID: 11075857 [TBL] [Abstract][Full Text] [Related]
16. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651 [TBL] [Abstract][Full Text] [Related]
19. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas]. Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795 [TBL] [Abstract][Full Text] [Related]
20. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]